Chemomab Therapeutics Ltd. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.28M, a 959.50% increase year-over-year.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $13.00K, a 18.18% increase year-over-year.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $121.00K, a 91.15% decline year-over-year.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $11.00K.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for fiscal 2020 was $3.00M, a 88.68% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. stock issued during period, value, new issues for fiscal 2019 was $26.50M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $1.28M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $13.00K 6-K · filed 2025-08-14 | |
| 2024-06-30 | $121.00K 6-K · filed 2025-08-14 | |
| 2024-03-31 | $11.00K 6-K · filed 2025-08-14 | |
| 2023-06-30 | $1.37M 6-K · filed 2024-08-21 | |
| 2021-06-30 | $15.12M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $3.00M 10-K · filed 2022-03-30 | |
| 2020-06-30 | $3.00M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $26.50M 10-K · filed 2021-03-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-16 | |
| 2019-03-31 | $26.50M 10-Q · filed 2020-08-14 |